Skip to main content
Fig. 1 | Clinical Epigenetics

Fig. 1

From: MicroRNA-100 and microRNA-21 as markers of survival and chemotherapy response in pancreatic ductal adenocarcinoma UICC stage II

Fig. 1

Prognostic impact of adjuvant gemcitabine treatment in PDAC UICC stage II patients. Improved overall (a) and recurrence-free survival (b) in patients with adjuvant gemcitabine treatment and good (n = 25) vs. bad (n = 39) response (p = 1.3628E-09; p = 2.8043E-15) and vs. no adjuvant gemcitabine treatment (n = 27) (p = 9.0791E-13; p = 1.565E-15). Improved overall survival in patients with bad chemotherapy response vs. no adjuvant treatment (p = 0.0093)

Back to article page

Clinical Epigenetics

ISSN: 1868-7083

Contact us